 Home > Medical News > Latest Medical News > The CDE issued a notice on the "Changes in the Working Procedures during the Review of Drug Registration Applications (Trial)"

The CDE issued a notice on the "Changes in the Working Procedures during the Review of Drug Registration Applications (Trial)"

 Last Update: 2022-11-26
 Source: Internet
 Author: User

Tags

diazepam drug

belsomra drug class

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Notice of the Center for Drug Review of the State Food and Drug Administration on the issuance of the "Work Procedures for Changes during the Review of Drug Registration Applications (Trial)" (Drug Review Industry [2022] No.
597)

Release date: 20221111

In order to cooperate with the implementation of the Measures for the Administration of Drug Registration, further standardize the changes during the review of drug registration applications, and ensure the safety, effectiveness and quality control of drugs, the Center for Drug Review has organized and formulated the "Working Procedures for Changes during the Review of Drug Registration Applications (Trial)" (see Annex), which is hereby issued after the review and consent of the State Medical Products Administration and will be implemented
from the date of promulgation.

Annex: Changes to the Working Procedures During the Review of Drug Registration Applications (Trial)

Drug Review Center, State Food and Drug Administration

November 9, 2022

Related attachments

serial number	Attachment name
1	. pdf the working procedures for changing during the review of drug registration applications
2	. doc confirmation of change of drug registration applicant

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.